Translated from our German original by AI. The German text was researched, written, and edited by the Psychedelia Foundation team and remains the authoritative version.
Running scientific studies with psychedelic substances is, in the view of researchers, often a lengthy, complex and bureaucratically demanding process. A new review titled “How to set up a psychedelic study: Unique considerations for research involving human participants” now brings together the experience of leading British research groups and offers practical recommendations for planning and carrying out such studies.
The authors stress that psychedelic research faces particular challenges that go well beyond conventional clinical trials. Alongside legal, political and pharmacological questions, sociocultural aspects, safety requirements, study design and the subjective experiences of participants all play a central role.
At the same time, research with psychedelics calls established assumptions in medicine and psychiatry into question. These include traditional approaches to psychiatric prescribing, the understanding of placebo effects, and basic concepts of identity and self-perception.
The review sets out to present these requirements, which have so far been little standardized, in a systematic way. Alongside an analysis of existing debates, it provides a practice-oriented guide for researchers and clinical trial centers. The recommendations are also addressed to policymakers, with the aim of creating suitable conditions for the further development of psychedelic research.
